We're Not Very Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Has the Norwegian Biotech Industry valuation changed over the past few years?
|Thu, 27 Jan 2022||kr30.5b||kr2.2b||kr68.6m||35.2x|
|Sat, 25 Dec 2021||kr41.3b||kr2.2b||kr51.3m||42.6x|
|Mon, 22 Nov 2021||kr37.1b||kr2.7b||kr486.5m||14.8x|
|Wed, 20 Oct 2021||kr37.3b||kr2.5b||kr445.2m||15.7x|
|Fri, 17 Sep 2021||kr39.1b||kr2.6b||kr512.3m||16x|
|Sun, 15 Aug 2021||kr39.3b||kr2.6b||kr508.1m||16.8x|
|Thu, 10 Jun 2021||kr42.3b||kr2.5b||kr545.4m||20x|
|Wed, 03 Mar 2021||kr40.1b||kr2.5b||kr652.4m||17.7x|
|Sat, 05 Dec 2020||kr31.1b||kr235.2m||-kr1,189,469,577.00||36.6x|
|Tue, 08 Sep 2020||kr25.9b||kr252.6m||-kr1,172,636,276.33||43.8x|
|Mon, 01 Jun 2020||kr22.1b||kr268.6m||-kr1,101,468,269.79||96.1x|
|Thu, 05 Mar 2020||kr12.8b||kr233.9m||-kr1,101,022,953.96||2.5x|
|Sun, 08 Dec 2019||kr9.5b||kr189.6m||-kr1,043,344,318.00||n/a|
|Sat, 31 Aug 2019||kr6.3b||kr176.3m||-kr1,022,520,318.00||n/a|
|Tue, 04 Jun 2019||kr5.7b||kr171.1m||-kr920,703,318.00||n/a|
|Fri, 08 Mar 2019||kr6.3b||kr162.4m||-kr917,558,318.00||n/a|
Current Industry PE: There are only 2 profitable companies in this industry, so there is insufficient data to make an industry-wide assessment of PE.
Past Earnings Growth: Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 139% per year. This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Which industries have driven the changes within the Norwegian Biotech industry?
Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 26.2x. However analysts are expecting annual earnings decline of 16%, which is lower than the prior year's growth of 57% per year. So the market might believe that analysts are underestimating future growth or they expect the Biotech industry's earnings to deteriorate the least compared to other industries.
Forecasted Growth: Despite it being negative, analysts are least pessimistic on the Biotech industry since they expect its earnings to decline by only 16% per year over the next 5 years, which isn't as bad as the other industries. However, this is a reversal from its past annual earnings growth rate of 57% per year.
Which companies have driven the market over the last 7 days?
PCI Biotech Holding